Literature DB >> 8496517

Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts.

P J de Feyter1, R J van Suylen, P P de Jaegere, E J Topol, P W Serruys.   

Abstract

OBJECTIVES: The purpose of this review is to assess the value and limitations of balloon angioplasty for the treatment of saphenous vein bypass graft obstructions. The potential efficacy of new interventional techniques is discussed.
BACKGROUND: Treatment of ischemia due to saphenous vein bypass graft obstructions poses a difficult problem that will be encountered more often as the pool of surgically treated patients continues to accumulate. Reoperation is technically demanding and is associated with high mortality and morbidity rates. Balloon angioplasty may provide a suitable alternative.
METHODS: The review proposes a classification of patients with attempted saphenous vein graft angioplasty according to expected early and late outcome based on the data obtained from the relevant published data and personal experience.
RESULTS: Angioplasty of a nonocclusive obstruction in a saphenous vein bypass graft has an initial success rate of approximately 90% and is a safe procedure (procedural death rate < 1%, myocardial infarction rate < 4%). The overall average restenosis rate is 42%. Surgical standby is limited and technically difficult. Angioplasty of chronic total occlusions in old grafts is associated with poor initial and long-term results. The long-term clinical results are unfavorable because of the continuing progression of disease in nontreated vein graft segments and native coronary arteries, in addition to the high restenosis rate. New techniques, although promising, have shown neither better initial results nor reduction of restenosis. Stent placement may be useful in longer graft lesions containing friable material.
CONCLUSIONS: Patients may be classified into three groups according to expected early and late outcome on the basis of 1) unfavorable graft anatomy, 2) risk of cardiogenic shock in event of acute graft closure, and 3) age of grafts. The three groups are 1) those with an initial high success, low procedural risk and low restenosis rate; 2) those with an initial high success but high procedural risk and moderate to high restenosis rate; and 3) those with a low success, high risk and high restenosis rate. Balloon angioplasty to treat lesions in venous bypass grafts should be considered a palliative procedure, not a long-term solution, for ongoing progression of coronary artery and vein graft disease. The induced high restenosis rate remains a significant problem.

Entities:  

Mesh:

Year:  1993        PMID: 8496517     DOI: 10.1016/0735-1097(93)90366-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions.

Authors:  Saami K Yazdani; Andrew Farb; Masataka Nakano; Marc Vorpahl; Elena Ladich; Aloke V Finn; Frank D Kolodgie; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

2.  Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting.

Authors:  Yin Liu; Xiujun Zhou; Hua Jiang; Mingdong Gao; Lin Wang; Yutian Shi; Jing Gao
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

3.  Cutting balloon angioplasty and stenting for aorto-ostial lesions.

Authors:  A S Kurbaan; P A Kelly; U Sigwart
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

Review 4.  Therapeutic strategies to combat neointimal hyperplasia in vascular grafts.

Authors:  Michael J Collins; Xin Li; Wei Lv; Chenzi Yang; Clinton D Protack; Akihito Muto; Caroline C Jadlowiec; Chang Shu; Alan Dardik
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-05

5.  Risk factors for the development of restenosis following stent implantation of venous bypass grafts.

Authors:  U E Heidland; M P Heintzen; C J Michel; B E Strauer
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

Review 6.  Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.

Authors:  J M Wilson; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1995

7.  Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO).

Authors:  T M Schiele; E Regar; S Silber; E Eeckhout; D Baumgart; W Wijns; A Colombo; W Rutsch; D Meerkin; A Gershlick; R Bonan; P Urban
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

8.  Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.

Authors:  Rajendra H Mehta; Deepak L Bhatt; Ph Gabriel Steg; Shinya Goto; Alan T Hirsch; Chiau-Suong Liau; Joachim Röther; Peter W F Wilson; Alain-Jean Richard; Kim A Eagle; E Magnus Ohman
Journal:  Eur Heart J       Date:  2008-11-07       Impact factor: 29.983

9.  Outcomes of percutaneous coronary intervention on saphenous vein graft and native coronary vessels.

Authors:  Mohammad Alidoosti; Seyed Kianoosh Hosseini; Ahmad Sharafi; Ebrahim Nematipour; Mojtaba Salarifar; Hamidreza Poorhoseini; Seyed Ebrahim Kassaian; Ali Mohammad Haji Zeinali; Alireza Amirzadegan; Mohammad Sadeghian; Masoumeh Lotfi-Tokalday
Journal:  J Tehran Heart Cent       Date:  2011-08-31

10.  Percutaneous transluminal renal angioplasty with stenting for stenotic venous bypass grafts: report of two cases.

Authors:  Masashi Kusakabe; Hiroki Sasaki; Jiro Sato; Masaaki Akahane; Tetsuro Miyata; Kuni Ohtomo
Journal:  Springerplus       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.